GSK
(OTC) GLAXF
GSK Financials at a Glance
Market Cap
$105.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
£30.74B
Net Income (TTM)
£5.35B
EPS (TTM)
$1.91
P/E Ratio
13.56
Dividend
$0.90
Beta (Volatility)
-0.12 (Low)
Dividend
$0.90
Beta (Volatility)
-0.12 (Low)
Price
$26.29
Volume
10
Open
$27.00
Price
$26.29
Volume
10
Open
$27.00
Previous Close
$26.29
Daily Range
$26.29 - $27.00
52-Week Range
$17.15 - $31.48
Estimated Earnings Date
Jul 28, 2026
Dividend
$0.90
Beta (Volatility)
-0.12 (Low)
Price
$26.29
Volume
10
Open
$27.00
Previous Close
$26.29
Daily Range
$26.29 - $27.00
52-Week Range
$17.15 - $31.48
Estimated Earnings Date
Jul 28, 2026
GLAXF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Luke Miels, MBA
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GLAXF Financials
Key Financial Metrics (TTM)
Gross Margin
72.74%
Operating Margin
22.34%
Net Income Margin
17.78%
Return on Equity
35.78%
Return on Capital
21.03%
Return on Assets
9.27%
Earnings Yield
7.37%
Dividend Yield
3.41%
Payout Ratio
44.52%
Stock Overview
Market Cap
$105.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
4.01B
Volume
10
Avg. Volume
1.03K
Financials (TTM)
Gross Profit
£22.34B
Operating Income
£7.25B
EBITDA
£10.50B
Operating Cash Flow
£7.63B
Capital Expenditure
-£1.97B
Free Cash Flow
£5.66B
Cash & ST Invst.
£3.44B
Total Debt
£19.10B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£7.63B
+1.5%
Gross Profit
£5.75B
+3.1%
Gross Margin
75.42%
N/A
Market Cap
$105.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.53M
N/A
Employees
68,629
N/A
Net Income
£1.74B
+7.0%
EBITDA
£2.77B
-10.3%
Quarterly Fundamentals
Total Cash
£3.44B
-23.2%
Total Debt
£19.10B
+3.6%
Accounts Receivable
£7.76B
+9.9%
Inventory
£6.16B
+2.6%
Long Term Debt
£14.05B
-14.7%
Short Term Debt
£5.06B
+158.3%
Return on Assets
9.27%
N/A
Return on Invested Capital
18.11%
N/A
Free Cash Flow
£698.00M
+0.1%
Operating Cash Flow
£1.14B
-0.3%